Product Information
88136-1-PBS targets SV2C in WB, Indirect ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Recombinant |
| Type | Antibody |
| Immunogen |
CatNo: Eg9076 Product name: Recombinant human SV2C protein Source: mammalian cells-derived, V37 Tag: C-rFc Domain: 459-578 aa of NM_014979.4 Sequence: KPLQSDEYALLTRNVERDKYANFTINFTMENQIHTGMEYDNGRFIGVKFKSVTFKDSVFKSCTFEDVTSVNTYFKNCTFIDTVFDNTDFEPYKFIDSEFKNCSFFHNKTGCQITFDDDYS Predict reactive species |
| Full Name | synaptic vesicle glycoprotein 2C |
| Calculated Molecular Weight | 83 kDa |
| Observed Molecular Weight | 120 kDa |
| GenBank Accession Number | NM_014979.4 |
| Gene Symbol | SV2C |
| Gene ID (NCBI) | 22987 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein A purification |
| UNIPROT ID | Q496J9 |
| Storage Buffer | PBS only, pH 7.3. |
| Storage Conditions | Store at -80°C. |
Background Information
Members of the synaptic vesicle glycoprotein 2 (SV2) family of proteins are involved in synaptic function throughout the brain. The ubiquitously expressed SV2A has been widely implicated in epilepsy, SV2C as a mediator of dopamine homeostasis and report that disrupted expression of SV2C within the basal ganglia is a pathological feature of PD. Genetic deletion of SV2C leads to reduced dopamine release in the dorsal striatum as measured by fast-scan cyclic voltammetry, reduced striatal dopamine content, disrupted α-synuclein expression, deficits in motor function, and alterations in neurochemical effects of nicotine. SV2C has a calculated molecular weight of ~82 kDa, but is detected at ~120 kDa by Western blot. This discrepancy is mainly due to extensive N‑glycosylation.



